bethanidine has been researched along with Cardiovascular Diseases in 2 studies
Bethanidine: A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study supplies enough evidences that Bethanidine is a potential inhibitor of SENP1 and can be applied for the treatment of cardiovascular diseases." | 8.12 | Computational drug repurposing of bethanidine for SENP1 inhibition in cardiovascular diseases treatment. ( Minuchehr, Z; Sabouni, F; Taghvaei, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taghvaei, S | 1 |
| Minuchehr, Z | 1 |
| Sabouni, F | 1 |
| Wilhelmsen, L | 1 |
| Berglund, G | 1 |
| Sannerstedt, R | 1 |
| Hansson, L | 1 |
| Andersson, O | 1 |
| Sievertsson, R | 1 |
| Wikstrand, J | 1 |
2 other studies available for bethanidine and Cardiovascular Diseases
| Article | Year |
|---|---|
Computational drug repurposing of bethanidine for SENP1 inhibition in cardiovascular diseases treatment.
Topics: Bethanidine; Cardiovascular Diseases; Cysteine Endopeptidases; Humans; Protein Binding; Sumoylation | 2022 |
Effect of treatment of hypertension in the primary preventive trial, Göteborg, Sweden.
Topics: Adrenergic beta-Antagonists; Bethanidine; Cardiovascular Diseases; Cerebrovascular Disorders; Corona | 1979 |